Home / RFI Lupus Research Program (LRP) Public / Document

FY27 LRP Request for Information survey monkey text

Updated

A Word document (22 KB) attached to RFI Lupus Research Program (LRP) Public, from the Defense Health Agency (DHA). Due Nov 16, 2026, 4:00 PM (UTC-5).

File name: FY27 LRP RFI survey monkey text_Final.docx

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview

DISCLAIMER: This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. The information requested shall be entered into Survey Monkey; therefore, the Government is unable to protect proprietary/sensitive information. Interested parties shall not submit proprietary/sensitive information through Survey Monkey. Responses to this RFI will not be returned. At this time, questions concerning the composition and requirements for a future RFP will not be entertained.

PURPOSE: The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform potential future Lupus Research Program (LRP) focus areas and associated research funding opportunities.

Although fiscal year 2027 funds have not been appropriated, the LRP is requesting this information to support program planning processes. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public.

This RFI is for information and planning purposes only and should not be construed as a solicitation or an obligation on the part of the LRP or the Department of War.

The following are the LRP’s current strategic goals.

Advance understanding of subsets of lupus patients, biologically or genetically, to improve appropriate treatment of these patients. Gain insight into disease mechanisms and heterogeneity by understanding responses to novel and existing interventions. Improve quality of life of patients.

From your perspective, are there critical gaps in the field that are not addressed by these strategic goals? If yes, please specify. Yes.
No.

[Comment Box]

The following are the LRP’s current focus areas.

Understanding how lupus disease heterogeneity impacts risk of disease, disease presentation, clinical course and outcomes using a diverse range of research disciplines including, but not limited to, biopsychosocial studies, personalized medicine, variation in treatment studies, health economics, socioeconomic studies, environmental studies, systems biology, maternal fetal health and epidemiological studies. Understanding the biological mechanisms of lupus disease including, but not limited to, studies of informative/rare patients.

The beginning of the document. Download the full file to read on.

Other documents in this bid